The new guidelines recommend isoniazid prophylaxis for at least 6 months in HIV-infected individuals in resource-constrained settings who do not have active TB.
For the first time in more than a decade, the WHO has issued new guidelines for preventing tuberculosis (TB) in HIV-infected individuals in resource-constrained settings. To date, the WHO has focused its HIV/TB efforts in such settings on intensified TB case-finding (ICF), isoniazid preventive therapy (IPT), and infection control. These new guidelines update the recommendations for ICF and IPT specifically. Each recommendation is graded as strong or conditional, and the supporting evidence is categorized as high, moderate, low, or very low.
Major recommendations are as follows:
All HIV-infected adults and adolescents should be screened for TB with a simple algorithm that relies on four clinical symptoms — cough, fever, weight loss, and night …
Reviewing Authors
Ashraf Mohammed, PhD, MSc (Med Sci)
Ashraf Mohammed, PhD, MSc (Med Sci)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)